Primary, secondary, and tertiary prevention of pre-eclampsia

[1]  B. Sibai,et al.  Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. , 2000, American journal of obstetrics and gynecology.

[2]  S. F. Olsen,et al.  Randomised clinical trials of fish oil supplementation in high risk pregnancies , 2000, BJOG : an international journal of obstetrics and gynaecology.

[3]  I. Doxiadis,et al.  Correlation between oral sex and a low incidence of preeclampsia: a role for soluble HLA in seminal fluid? , 2000, Journal of reproductive immunology.

[4]  K. Khan,et al.  How useful is uterine artery Doppler flow velocimetry in the prediction of pre‐eclampsia, intrauterine growth retardation and perinatal death? An overview , 2000, BJOG : an international journal of obstetrics and gynaecology.

[5]  G Koren,et al.  Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis , 2000, The Lancet.

[6]  B. Sibai,et al.  Pregnancy Outcomes in Healthy Nulliparas Who Developed Hypertension , 2000, Obstetrics and gynecology.

[7]  A. Conde-Agudelo,et al.  Risk factors for pre‐eclampsia in a large cohort of Latin American and Caribbean women , 2000, BJOG : an international journal of obstetrics and gynaecology.

[8]  C. J. Colby,et al.  Second-trimester serum chorionic gonadotropin concentrations and complications and outcome of pregnancy. , 1999, The New England journal of medicine.

[9]  Y. T. van der Schouw,et al.  Adverse obstetric outcome in low- and high- risk pregnancies: predictive value of maternal serum screening. , 1999, Obstetrics and gynecology.

[10]  C. O'Herlihy,et al.  Maternal central hemodynamics in hypertensive disorders of pregnancy. , 1999, Obstetrics and gynecology.

[11]  S. Bell,et al.  Dipstick proteinuria: caveat emptor , 1999, British journal of obstetrics and gynaecology.

[12]  H. V. van Geijn,et al.  Change in paternity: a risk factor for preeclampsia in multiparous women? , 1999, Journal of reproductive immunology.

[13]  A. Many,et al.  Treatment of severe preeclampsia remote from term: a clinical dilemma. , 1999, Obstetrical & gynecological survey.

[14]  L. Poston,et al.  Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial , 1999, The Lancet.

[15]  G. Dekker.  Risk factors for preeclampsia. , 1999, Clinical obstetrics and gynecology.

[16]  R. Dersimonian,et al.  Resolving discrepancies between a meta-analysis and a subsequent large controlled trial. , 1999, JAMA.

[17]  A. Mander,et al.  Low dose aspirin for preventing and treating pre-eclampsia , 1999, BMJ.

[18]  L. Magee,et al.  Fortnightly review: management of hypertension in pregnancy. , 1999, BMJ.

[19]  T. Hulsey,et al.  Revisiting the epidemiological standard of preeclampsia: primigravidity or primipaternity? , 1999, European journal of obstetrics, gynecology, and reproductive biology.

[20]  Jeffrey S. Robinson,et al.  Calcium Supplementation In Nulliparous Women For The Prevention Of Pregnancy‐Induced Hypertension, Preeclampsia And Preterm Birth: An Australian Randomized Irial , 1999 .

[21]  I. Sargent,et al.  Preeclampsia: an excessive maternal inflammatory response to pregnancy. , 1999, American journal of obstetrics and gynecology.

[22]  A. Flahault,et al.  Effect of aspirin in pregnant women is dependent on increase in bleeding time. , 1999, American journal of obstetrics and gynecology.

[23]  D. Campbell,et al.  Preeclampsia in twin pregnancies: incidence and outcome. , 1999, Hypertension in pregnancy.

[24]  G. Thurnau,et al.  Plasma ferritin, premature rupture of membranes, and pregnancy outcome. , 1998, American journal of obstetrics and gynecology.

[25]  H. V. van Geijn,et al.  Vasoactive mediators in pregnancy-induced hypertensive disorders: a longitudinal study. , 1998, American journal of obstetrics and gynecology.

[26]  B. Sibai,et al.  Etiology and pathogenesis of preeclampsia: current concepts. , 1998, American journal of obstetrics and gynecology.

[27]  J. D. Vries,et al.  Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction. , 1998, American journal of obstetrics and gynecology.

[28]  T. Hulsey,et al.  Immune maladaptation in the etiology of preeclampsia: a review of corroborative epidemiologic studies. , 1998, Obstetrical & gynecological survey.

[29]  R. T. Lie,et al.  Fetal and maternal contributions to risk of pre-eclampsia: population based study , 1998, BMJ.

[30]  S. Robertson,et al.  Seminal transforming growth factor beta1 stimulates granulocyte-macrophage colony-stimulating factor production and inflammatory cell recruitment in the murine uterus. , 1998, Biology of reproduction.

[31]  S. Bewley,et al.  Pre‐eclamptic toxaemia: the role of uterine artery Doppler , 1998, British journal of obstetrics and gynaecology.

[32]  H. Odendaal,et al.  Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia , 1997, The Lancet.

[33]  J. Cutler,et al.  Trial of calcium to prevent preeclampsia. , 1997, The New England journal of medicine.

[34]  M. Schemper,et al.  A meta‐analysis of low dose aspirin for the prevention of intrauterine growth retardation , 1997, British journal of obstetrics and gynaecology.

[35]  R. Carpenter,et al.  Transvaginal Doppler ultrasound of the uteroplacental circulation in the early prediction of pre‐eclampsia and intrauterine growth retardation , 1996, British journal of obstetrics and gynaecology.

[36]  J. Moodley,et al.  Drug management of hypertensive disorders of pregnancy. , 1997, Pharmacology & therapeutics.

[37]  F. Zijlstra,et al.  Nicotine inhibits the in vitro production of interleukin 2 and tumour necrosis factor-alpha by human mononuclear cells. , 1996, Immunopharmacology.

[38]  L. Trupin,et al.  Change in Paternity: A Risk Factor for Preeclampsia in Multiparas , 1996, Epidemiology.

[39]  R. Collins,et al.  WHICH ANTICONVULSANT FOR WOMEN WITH ECLAMPSIA - EVIDENCE FROM THE COLLABORATIVE ECLAMPSIA TRIAL , 1995 .

[40]  B. Sibai,et al.  Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. , 1995, American journal of obstetrics and gynecology.

[41]  G. Cutter,et al.  Fetal Growth in Women Using Low-Dose Aspirin for the Prevention of Preeclampsia: Effect of Maternal Size , 1995 .

[42]  T. Hulsey,et al.  Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception , 1994, The Lancet.

[43]  Gnm Pamela Platis.  Risk factors for severe preeclampsia: Stone JL, Lockwood CJ, Berkowitz GS, Alvarez M, Lapinski R, Berkowttz RL. Obstet Gynecol 1994; 83:357–361 , 1994 .

[44]  J. Bonnar,et al.  Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre‐eclampsia , 1994, British journal of obstetrics and gynaecology.

[45]  Jeffrey R. Wilson,et al.  CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women , 1994, The Lancet.

[46]  R L Berkowitz,et al.  Risk Factors for Severe Preeclampsia , 1994, Obstetrics and gynecology.

[47]  S. Walsh.  LIPID PEROXIDATION IN PREGNANCY , 1994 .

[48]  J. Moodley,et al.  Prophylactic Anticonvulsant Therapy in Hypertensive Crises of Pregnancy—The Need for a Large, Randomized Trial , 1994 .

[49]  D. Haig,et al.  Genetic Conflicts in Human Pregnancy , 1993, The Quarterly Review of Biology.

[50]  A. Conde-Agudelo,et al.  What does an elevated mean arterial pressure in the second half of pregnancy predict--gestational hypertension or preeclampsia? , 1993, American journal of obstetrics and gynecology.

[51]  J. Moutquin,et al.  A prospective study of several potential biologic markers for early prediction of the development of preeclampsia. , 1993, American journal of obstetrics and gynecology.

[52]  C. Dinarello,et al.  Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. , 1993, Blood.

[53]  T. Hulsey,et al.  Paternity patterns and risk of preeclampsia in the last pregnancy in multiparae. , 1993, Journal of reproductive immunology.

[54]  B. Sibai,et al.  Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: Rationale, mechanisms, and clinical trials , 1993 .

[55]  P. Weber,et al.  Cardiovascular effects of N-3 fatty acids. , 1988, Journal of nutritional science and vitaminology.

[56]  B. Sibai,et al.  Early detection of preeclampsia. , 1991, American journal of obstetrics and gynecology.

[57]  J. Brisson,et al.  Calcium intake from dairy products and supplements and the risks of preeclampsia and gestational hypertension. , 1991, American journal of epidemiology.

[58]  J. Grudzinskas,et al.  Repeated measurement of maternal weight during pregnancy. Is this a useful practice? , 1991, British journal of obstetrics and gynaecology.

[59]  B. Sibai,et al.  Clinical significance of elevated mean arterial blood pressure in second trimester and threshold increase in systolic or diastolic blood pressure during third trimester. , 1989, American journal of obstetrics and gynecology.

[60]  R. Newcombe,et al.  RELATION OF HAEMOGLOBIN LEVELS IN FIRST AND SECOND TRIMESTERS TO OUTCOME OF PREGNANCY , 1986, The Lancet.

[61]  U. Herrmann,et al.  Immunogestosis: a new etiologic concept of "essential" EPH gestosis, with special consideration of the primigravid patient; preliminary report of a clinical study. , 1977, American journal of obstetrics and gynecology.

[62]  D. Mckie.  Family planning in the National Health Service. , 1973, Lancet.